Universal American Corp. v. Partners Healthcare Solutions Holdings, L.P.
176 F. Supp. 3d 387
D. Del.2016Background
- Universal American Corp. acquired Partners Healthcare Solutions, Inc. (APS); post-closing APS underperformed dramatically and Universal alleges an organized fraud that rendered APS’s forecasts and contract pipelines false.
- APS was held by APSLP, a partnership controlled by GTCR-related funds; key APS officers (Scott — CEO, Vaccaro — COO/President, McDonough — CFO) and David Katz (GTCR) were involved in negotiations and due diligence.
- Universal pleaded securities fraud (§ 10(b)), control-person liability (§ 20(a)), common-law fraud (contractual and extra-contractual), and related claims across numerous defendants.
- Defendants moved to dismiss many counts under Rules 8, 9(b), and 12(b)(6); the Court considered particularity, scienter, reliance, control, and the effect of anti-reliance/integration clauses in the merger agreement.
- The Court granted dismissal in part and denied in part: it sustained some §10(b) and common-law fraud claims against certain defendants (notably Scott, McDonough, APSLP, Katz) but dismissed claims as to Vaccaro under §10(b), dismissed the §20(a) claim against the Individual Defendants and APSLP, and rejected fraud claims based on extra-contractual statements where the merger agreement contained an effective anti-reliance/integration clause.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Whether §10(b) fraud pleaded with PSLRA particularity and scienter | Universal alleges specific misrepresentations in the Merger Agreement/Officer’s Certificate and oral misstatements by McDonough, plus motive and rapid forecast reductions supporting scienter | Defendants say pleadings are group pleadings, lack individualized "maker" allegations, lack strong scienter, and reliance is unpled | Denied as to APSLP, Scott, McDonough (pleading adequate); granted as to Vaccaro (no individualized allegations) |
| Whether universal pleaded reliance (transaction causation) for pre-signing extra-contractual statements | Universal contends it relied on defendants’ representations in deciding to acquire APS and to close | Defendants contend Universal cannot show reliance on extra-contractual statements given integration/anti-reliance clauses | Court found plaintiff’s reliance allegations adequate for §10(b) (transaction causation) but later limited common-law fraud claims by contract terms (see below) |
| Whether §20(a) control-person claims adequately pleaded against Katz, Scott, Vaccaro, McDonough, APSLP | Universal alleges Katz and GTCR were hands-on, Katz negotiated material terms, and the Individual Defendants exercised control and culpable participation | Defendants argue plaintiffs cannot be both primary violators and controlling persons and that control/culpable participation are not pled with particularity | Denied as to Katz/GTCR (Count III survives); Count II dismissed as to Scott, Vaccaro, McDonough, APSLP for failure to plead control/culpable participation with required particularity |
| Whether common-law fraud claims based on extra-contractual statements/omissions survive given merger agreement anti-reliance/integration clauses | Universal asserts fraud claims based on extra-contractual statements and omissions (pre- and post-signing) and on contractual representations | Defendants invoke merger Section 3.34 and integration clause as clear anti-reliance, barring extra-contractual fraud claims | Court held anti-reliance/integration language barred claims based on extra-contractual statements/omissions (Counts VII, VIII, IX, and portions of X, XI, XIII dismissed); claims based on contractual misstatements in the Merger Agreement and Officer’s Certificate survive against APSLP and certain individuals |
Key Cases Cited
- Amgen Inc. v. Connecticut Retirement Plans & Trust Funds, 133 S. Ct. 1184 (U.S. 2013) (elements of a §10(b) claim)
- Janus Capital Grp., Inc. v. First Derivative Traders, 131 S. Ct. 2296 (U.S. 2011) (definition of the “maker” of a statement for §10(b) liability)
- Tellabs, Inc. v. Makor Issues & Rights, Ltd., 551 U.S. 308 (U.S. 2007) (standard for pleading a strong inference of scienter)
- Institutional Investors Group v. Avaya, Inc., 564 F.3d 242 (3d Cir. 2009) (PSLRA particularity and scienter analysis in Third Circuit)
- Abry Partners V, L.P. v. F & W Acquisition LLC, 891 A.2d 1032 (Del. Ch. 2006) (Delaware law permitting fraud claims based on contractual representations)
- Prairie Capital III, L.P. v. Double E Holding Corp., 132 A.3d 35 (Del. Ch. 2015) (integration/anti-reliance clauses can bar extra-contractual omission-based fraud claims)